These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease. Smailovic U; Kåreholt I; Koenig T; Ashton NJ; Winblad B; Höglund K; Nilsson P; Zetterberg H; Blennow K; Jelic V J Alzheimers Dis; 2021; 83(1):355-366. PubMed ID: 34334389 [TBL] [Abstract][Full Text] [Related]
14. C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease. De Vos A; Jacobs D; Struyfs H; Fransen E; Andersson K; Portelius E; Andreasson U; De Surgeloose D; Hernalsteen D; Sleegers K; Robberecht C; Van Broeckhoven C; Zetterberg H; Blennow K; Engelborghs S; Vanmechelen E Alzheimers Dement; 2015 Dec; 11(12):1461-1469. PubMed ID: 26092348 [TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139 [TBL] [Abstract][Full Text] [Related]
16. The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease. De Vos A; Struyfs H; Jacobs D; Fransen E; Klewansky T; De Roeck E; Robberecht C; Van Broeckhoven C; Duyckaerts C; Engelborghs S; Vanmechelen E J Alzheimers Dis; 2016 Jul; 53(4):1523-38. PubMed ID: 27392859 [TBL] [Abstract][Full Text] [Related]
17. Association of cerebrospinal fluid Neurogranin with Alzheimer's disease. Wang L; Aging Clin Exp Res; 2019 Feb; 31(2):185-191. PubMed ID: 29667155 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182 [TBL] [Abstract][Full Text] [Related]
19. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies. Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969 [TBL] [Abstract][Full Text] [Related]
20. CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD. Gispert JD; Monté GC; Falcon C; Tucholka A; Rojas S; Sánchez-Valle R; Antonell A; Lladó A; Rami L; Molinuevo JL Neurobiol Aging; 2016 Feb; 38():47-55. PubMed ID: 26827642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]